Home
  >  
Section 49
  >  
Chapter 48,212

Alpha-Galactosyl trisaccharide epitope: Modification of the 6-primary positions and recognition by human anti-alphaGal antibody

Andreana, P.R.; Kowal, P.; Janczuk, A.J.; Wang, P.G.

Glycoconjugate Journal 20(2): 107-118

2004

ISSN/ISBN: 0282-0080
PMID: 15001843
DOI: 10.1023/b:glyc.0000018585.66094.ff
Accession: 048211483
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Galactose oxidase (EC 1.1.3.9, GAO) was used to convert the C-6' OH of Galbeta(1 --> 4)Glcbeta-OBn (5) to the corresponding hydrated aldehyde (7). Chemical modification, through dehydratative coupling and reductive amination, gave rise to a small library of Galbeta(1 --> 4)Glcbeta-OBn analogues (9a-f, 10, 11). UDP-[6-(3)H]Gal studies indicated that alpha1,3-galactosyltransferase recognized the C-6' modified Galbeta(1 --> 4)Glcbeta-OBn analogues (9a-f, 10, 11). Preparative scale reactions ensued, utilizing a single enzyme UDP-Gal conversion as well as a dual enzymatic system (GalE and alpha1,3GalT), taking full advantage of the more economical UDP-Glc, giving rise to compounds 6, 15-22. Galalpha(1 --> 3)Galbeta(1 --> 4)Glcbeta-OBn trisaccharide (6) was produced on a large scale (2 g) and subjected to the same chemoenzymatic modification as stated above to produce C-6" modified derivatives (23-30). An ELISA bioassay was performed utilizing human anti-alphaGal antibodies to study the binding affinity of the derivatized epitopes (6, 15-30). Modifications made at the C-6' position did not alter the IgG antibody's ability to recognize the unnatural epitopes. Modifications made at the C-6" position resulted in significant or complete abrogation of recognition. The results indicate that the C-6' OH of the alphaGal trisaccharide epitope is not mandatory for antibody recognition.

PDF emailed within 0-6 h: $19.90




Related References

Zhang, Z.; Tishler, D.; Tsang, W.; Kaptanoglu, L.; Leventhal, J.; Kaufman, D.; Abecassis, M.; Anderson, B.; Fryer, J. 2001: Use of chicken anti-alphaGal antibodies in preventing anti-alphaGal antibody mediated cardiac graft rejection in alphaGal KO mice Xenotransplantation 8(Suppl 1): 99-100
Gollogly, L.; Castronovo, V. 1996: A possible role for the alpha 1-->3 galactosyl epitope and the natural anti-gal antibody in oncogenesis Neoplasma 43(5): 285-289
Vecchi, M.L.; Davin, J.C.; Castronovo, V.; Foidart, J.M.; Malaise, M.; Foidart, J.B.; Dechene, C.; Sangiorgi, G.B.; Mahieu, P. 1989: Reactivity of human anti-alpha-galactosyl IgG antibody with alpha(1-->3)-linked galactosyl epitopes exposed on basement membranes and on glomerular epithelial cells: an in vitro and in vivo study in the mouse Clinical and Experimental Immunology 78(2): 271-277
Li, J.; Ksebati, M.B.; Zhang, W.; Guo, Z.; Wang, J.; Yu, L.; Fang, J.; Wang, P.G. 1999: Conformational analysis of an alpha-galactosyl trisaccharide epitope involved in hyperacute rejection upon xenotransplantation Carbohydrate Research 315(1-2): 76-88
Zhang, W.; Wang, J.; Li, J.; Yu, L.; Wang, P.G.orge 1999: Large scale synthesis of a derivative of an alpha-galactosyl trisaccharide epitope involved in the hyperacute rejection of xenotransplantation Journal of Carbohydrate Chemistry 18(8): 1009-1017
Teneberg, S.; Lönnroth, I.; Torres López, J.F.; Galili, U.; Halvarsson, M.O.; Angström, J.; Karlsson, K.A. 1996: Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor Glycobiology 6(6): 599-609
Macher, B.A.; Clark, M.R.; Shohet, S.B.; Buehler, J.; Galili, U. 1986: Evolutionary relationship between the anti alpha galactosyl antibody and its alpha galactosyl binding site in primates Federation Proceedings 45(6): 1824
Magre, S.; Takeuchi, Y.; Langford, G.; Richards, A.; Patience, C.; Weiss, R. 2004: Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope Journal of Virology 78(11): 5812-5819
Xu, Y.; Thall, A. 1998: Comparison of natural antibody production specific for the alpha-galactosyl epitope in humans, non-human primates, and mice by ELISPOT FASEB Journal 12(5): A1059
Galili, U.; Macher, B.A.; Buehler, J.; Shohet, S.B. 1985: Human natural anti-alpha-galactosyl IgG. II. the specific recognition of alpha (1----3)-linked galactose residues Journal of Experimental Medicine 162(2): 573-582
Bundle, D.R.; Eichler, E.; Gidney, M.A.J.; Meldal, M.; Ragauskas, A.; Sigurskjold, B.W.; Sinnott, B.; Watson, D.C.; Yaguchi, M.; Young, N.M. 1994: Molecular Recognition of a Salmonella Trisaccharide Epitope by Monoclonal Antibody Se155-4 Biochemistry 33(17): 5172-5182
Bundle, D.R.; Eichler, E.; Gidney, M.A.; Meldal, M.; Ragauskas, A.; Sigurskjold, B.W.; Sinnott, B.; Watson, D.C.; Yaguchi, M.; Young, N.M. 1994: Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4 Biochemistry 33(17): 5172-5182
Galili, U. 1993: Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody Springer Seminars in Immunopathology 15(2-3): 155-171
Rother, R.P.; Springhorn, J.P.; Fodor, W.L.; Squinto, S.P.; Rollins, S.A. 1995: Antibody-dependent inactivation of retroviral vector particles by human serum mediated by anti-alpha-galactosyl natural antibody Journal of Cellular Biochemistry Suppl 1995(21A): 414
Gowda, D.C. 1998: Modification at C6 of the terminal galactosyl residues of cobra venom factor abolishes anti-alpha-Gal antibody immunoreactivity without affecting functional activity Biochemical and Biophysical Research Communications 245(1): 28-32
Hanessian, S.; Saavedra, O.M.; Mascitti, V.; Marterer, W.; Oehrlein, R.; Mak, C.P.ng 2001: Practical syntheses of B disaccharide and linear B type 2 trisaccharide: Non-primate epitope markers recognized by human anti-alpha-Gal antibodies causing hyperacute rejection of xenotransplants Tetrahedron 57(16): 3267-3280, 16 April
Galili, U.; Rachmilewitz, E.A.; Peleg, A.; Flechner, I. 1984: A unique natural human IgG antibody with anti-alpha-galactosyl specificity Journal of Experimental Medicine 160(5): 1519-1531
Dehoux, J.P.; De La Parra, B.; Squifflet, J.P.; Latinne, D.; Bazin, H.; Gianello, P. 2001: Human and non-human primate anti-galactosyl response after injection of rat monoclonal antibody bearing galactosyl epitopes Xenotransplantation 8(Suppl 1): 92
Dehoux, J.P.; de la Parra, B.; Latinne, D.; Bazin, H.; Squifflet, J.P.; Gianello, P. 2000: Human and non-human primate anti-galactosyl response after injection of rat monoclonal antibody bearing galactosyl epitopes Xenotransplantation 7(2): 109-117
Aguirre, A.; Escobar, A.; Ferreira, V.; Molina, M.ía.C.; Ferreira, A.; Aguillón, J.C. 2003: An anti-human recombinant tumor necrosis factor alpha (TNF alpha) monoclonal antibody recognizes an epitope in feline TNF alpha Veterinary Research 34(2): 177-184